tlo.methods.prostate_cancer module
==================================

.. automodule:: tlo.methods.prostate_cancer


.. autoclass:: ProstateCancer

     Bases: :class:`tlo.core.Module`, :class:`tlo.methods.hsi_generic_first_appts.GenericFirstAppointmentsMixin`


     **PARAMETERS:**
     
     .. list-table::
        :widths: 25 25 50
        :header-rows: 1
     
        * - Item
          - Type
          - Description
        * - init_prop_prostate_ca_stage
          - LIST
          - initial proportions in prostate cancer stages for men aged 35-49
        * - init_prop_urinary_symptoms_by_stage
          - LIST
          - initial proportions of those in prostate ca stages that have urinary symptoms
        * - init_prop_pelvic_pain_symptoms_by_stage
          - LIST
          - initial proportions of those in prostate ca stages that have pelvic pain symptoms
        * - init_prop_with_urinary_symptoms_diagnosed_prostate_ca_by_stage
          - LIST
          - initial proportions of people with prostate ca and urinary symptoms that have been diagnosed
        * - init_prop_with_pelvic_pain_symptoms_diagnosed_prostate_ca_by_stage
          - LIST
          - initial proportions of people with prostate ca and pelvic pain symptoms that have been diagnosed
        * - init_prop_treatment_status_prostate_ca
          - LIST
          - initial proportions of people with prostate ca that had received treatment
        * - init_prob_palliative_care
          - REAL
          - initial probability of being under palliative care if at metastatic stage
        * - r_prostate_confined_prostate_ca_none
          - REAL
          - probabilty per 3 months of incident (prostate confined) prostate cancer amongst people with no prostate ca (men, age35-49)
        * - rr_prostate_confined_prostate_ca_age5069
          - REAL
          - rate ratio for incident (prostate confined) prostate cancer amongst men aged 50-69
        * - rr_prostate_confined_prostate_ca_agege70
          - REAL
          - rate ratio for incident (prostate confined) prostate cancer amongst men aged ge 70
        * - r_local_ln_prostate_ca_prostate_confined
          - REAL
          - probabilty per 3 months of local lymph node involved prostate ca amongst people with prostate confined prostate ca
        * - rr_local_ln_prostate_ca_undergone_curative_treatment
          - REAL
          - rate ratio for local lymph node involved prostate ca for people with prostate confined prostate cadue to undergoing curative treatment
        * - r_metastatic_prostate_ca_local_ln
          - REAL
          - probabilty per 3 months of metastatic prostate cancer amongst people with local lymph nodeinvolved prostate ca
        * - rr_metastatic_prostate_ca_undergone_curative_treatment
          - REAL
          - rate ratio for metastatic prostate cancer stage 1 for people with lymph node involved prostate ca due toundergoing curative treatment
        * - rate_palliative_care_metastatic_prostate_ca
          - REAL
          - prob palliative care this 3 month period if metastatic prostate ca
        * - r_death_metastatic_prostate_cancer
          - REAL
          - probabilty per 3 months of death from prostate cancer mongst people with metastatic prostate cancer
        * - r_urinary_symptoms_prostate_ca
          - REAL
          - rate of urinary symptoms if have prostate confined prostate ca
        * - rr_urinary_symptoms_local_ln_or_metastatic_prostate_cancer
          - REAL
          - rate ratio of urinary symptoms in a person with local lymph node or metastatuc prostate cancer compared with prostate confined prostate ca
        * - r_pelvic_pain_symptoms_local_ln_prostate_ca
          - REAL
          - rate of pelvic pain or numbness symptoms if have local lymph node involved prostate cancer
        * - rr_pelvic_pain_metastatic_prostate_cancer
          - REAL
          - rate ratio of pelvic pain or numbness in a person with metastatic prostate cancer compared with lymph node involved prostate cancer
        * - rp_prostate_cancer_age5069
          - REAL
          - stage-specific relative prevalence at baseline of prostate cancer for age 50-69
        * - rp_prostate_cancer_agege70
          - REAL
          - stage-specific relative prevalence at baseline of prostate cancer for age 70+
        * - sensitivity_of_psa_test_for_prostate_ca
          - REAL
          - sensitivity of psa test for prostate cancer
        * - sensitivity_of_biopsy_for_prostate_ca
          - REAL
          - sensitivity of biopsy for prostate cancer


     **PROPERTIES:**
     
     .. list-table::
        :widths: 25 25 50
        :header-rows: 1
     
        * - Item
          - Type
          - Description
        * - pc_status
          - CATEGORICAL
          - Current status of the health condition, prostate cancer.  Possible values are: [none, prostate_confined, local_ln, metastatic, ]
        * - pc_date_psa_test
          - DATE
          - the date of psa test in response to symptoms
        * - pc_date_biopsy
          - DATE
          - the date of biopsy in response to symptoms and positive psa test
        * - pc_date_diagnosis
          - DATE
          - the date of diagnosis of the prostate cancer (pd.NaT if never diagnosed)
        * - pc_date_treatment
          - DATE
          - date of first receiving attempted curative treatment (pd.NaT if never started treatment)
        * - pc_stage_at_which_treatment_given
          - CATEGORICAL
          - the cancer stage at which treatment is given (because the treatment only has an effect during the stageat which it is given..  Possible values are: [none, prostate_confined, local_ln, metastatic, ]
        * - pc_date_palliative_care
          - DATE
          - date of first receiving palliative care (pd.NaT is never had palliative care)
        * - pc_date_death
          - DATE
          - date pc death



     **Class attributes:**

     CAUSES_OF_DEATH : {'ProstateCancer': <tlo.methods.causes.Cause object at 0x31b272bd0>}

     CAUSES_OF_DISABILITY : {'ProstateCancer': <tlo.methods.causes.Cause object at 0x31b270dd0>}

     INIT_DEPENDENCIES : {'SymptomManager', 'Demography', 'HealthSystem'}

     METADATA : {<Metadata.USES_SYMPTOMMANAGER: 2>, <Metadata.USES_HEALTHBURDEN: 4>, <Metadata.USES_HEALTHSYSTEM: 3>, <Metadata.DISEASE_MODULE: 1>}

     OPTIONAL_INIT_DEPENDENCIES : {'HealthBurden'}

     __annotations__ : {}

     **Functions (defined or overridden in class ProstateCancer):**

     .. automethod:: __init__

     .. automethod:: read_parameters

     .. automethod:: initialise_population

     .. automethod:: initialise_simulation

     .. automethod:: on_birth

     .. automethod:: on_hsi_alert

     .. automethod:: report_daly_values

     .. automethod:: do_at_generic_first_appt








.. autoclass:: ProstateCancerMainPollingEvent

     Bases: :class:`tlo.events.RegularEvent`, :class:`tlo.events.Event`, :class:`tlo.events.PopulationScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class ProstateCancerMainPollingEvent):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_Investigation_Following_Urinary_Symptoms

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_Investigation_Following_Urinary_Symptoms):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_Investigation_Following_Pelvic_Pain

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_Investigation_Following_Pelvic_Pain):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_Investigation_Following_psa_positive

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_Investigation_Following_psa_positive):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_StartTreatment

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_StartTreatment):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_PostTreatmentCheck

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_PostTreatmentCheck):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: HSI_ProstateCancer_PalliativeCare

     Bases: :class:`tlo.methods.hsi_event.HSI_Event`, :class:`tlo.events.IndividualScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class HSI_ProstateCancer_PalliativeCare):**

     .. automethod:: __init__

     .. automethod:: apply








.. autoclass:: ProstateCancerLoggingEvent

     Bases: :class:`tlo.events.RegularEvent`, :class:`tlo.events.Event`, :class:`tlo.events.PopulationScopeEventMixin`



     **Class attributes:**

     __annotations__ : {}

     **Functions (defined or overridden in class ProstateCancerLoggingEvent):**

     .. automethod:: __init__

     .. automethod:: apply





